Info

Siegel GJ, Chauhan NB. Neurotrophic factors in Alzheimer's and Parkinson's disease brain. Brain Res Brain Res Rev. 33: 199-227, 2000.

Salehi A, Delcroix JD, Swaab DF. Alzheimer's disease and NGF signaling. J Neural Transm. 111: 323-345, 2004.

Mutoh T, Sobue G, Hamano T, Kuriyama M, Hirayama M, Yamamoto M, Mitsuma T. Decreased phospho-rylation levels of TrkB neurotrophin receptor in the spinal cords from patients with amyotrophic lateral sclerosis. Neurochem Res. 25: 239-245, 2000.

Sly LM, Krzesicki RF, Brashler JR, Buhl AE, McKinley DD, Carter DB, Chin JE. Endogenous brain cytokine mRNA and inflammatory responses to lipopolysaccharide are elevated in the Tg2576 transgenic mouse model of Alzheimer's disease. Brain Res Bull. 56: 581-588, 2001.

245. McGeer EG, McGeer PL. Role of neural-immune interactions in neurodegenerative diseases. In: Clinical Neuroimmunology, 2nd Edition (Antel J, Birnbaum G, Hartung HP, Vincent A, eds.). Oxford Univeristy Press, Oxford, pp. 355-363, 2005.

246. Tuppo EE, Arias HR. The role of inflammation in Alzheimer's disease. Int J Biochem Cell Biol. 37: 289-305, 2005.

247. Streit WJ. Microglia and Alzheimer's disease pathogenesis. J Neurosci Res. 77: 1-8, 2004.

248. Christov A, Ottman JT, Grammas P. Vascular inflammatory, oxidative and protease-based processes: implications for neuronal cell death in Alzheimer's disease. Neurol Res. 26: 540-546, 2004.

249. Walker DG, Lue LF. Microglial responses in Alzheimer's disease. In: Neuroinflammation - Mechanisms and Management, 2nd Edition (Wood PL, ed.). Humana Press, Totowa, NJ, pp. 267-282, 2003.

250. Guo Q, Sebastian L, Sopher BL, Miller MW, Glazner GW, Ware CB, Martin GM, Mattson MP. Neurotrophic factors [activity-dependent neurotrophic factor (ADNF) and basic fibroblast growth factor (bFGF)] interrupt excitotoxic neurodegenerative cascades promoted by a PS1 mutation. Proc Natl Acad Sci USA 96: 4125-4130, 1999.

251. Hirsch EC, Breidert T, Rousselet E, Hunot S, Hartmann A, Michel PP. The role of glial reaction and inflammation in Parkinson's disease. Ann NY Acad Sci. 991: 214-228, 2003.

252. Zhou Y, Wang Y, Kovacs M, Jin J, Zhang J. Microglial activation induced by neurodegeneration: a proteomic analysis. Mol Cell Proteomics 4: 1471-1479, 2005.

253. Orr CF, Rowe DB, Mizuno Y, Mori H, Halliday GM. A possible role for humoral immunity in the pathogenesis of Parkinson's disease. Brain 128: 2665-2674, 2005.

254. Imamura K, Hishikawa N, Ono K, Suzuki H, Sawada M, Nagatsu T, Yoshida M, Hashizume Y. Cytokine production of activated microglia and decrease in neurotrophic factors of neurons in the hippocampus of Lewy body disease brains. Acta Neuropathol (Berl). 109: 141-150, 2005.

255. Ouchi Y, Yoshikawa E, Sekine Y, Futatsubashi M, Kanno T, Ogusu T, Torizuka T. Microglial activation and dopamine terminal loss in early Parkinson's disease. Ann Neurol. 57: 168-175, 2005.

256. Nicotera P, Leist M, Ferrando-May E. Apoptosis and necrosis: different execution of the same death. Biochem Soc Symp. 66: 69-73, 1999.

257. Jellinger KA. General aspects of neurodegeneration. J Neural Transm. Suppl. 65: 101-144, 2003.

258. Wyllie AH. Apoptosis: an overview. Br Med Bull. 53: 451-465, 1997.

259. 259de Almeida CJ, Linden R. Phagocytosis of apoptotic cells: a matter of balance. Cell Mol Life Sci. 62: 1532-1546, 2005.

260. Harwood SM, Yaqoob MM, Allen DA. Caspase and calpain function in cell death: bridging the gap between apoptosis and necrosis. Ann Clin Biochem. 42: 415-431, 2005.

260a. Mattson P, Bazan NG. Apoptosis and necrosis. In: Basic Neurochemistry, 7th Edition, (Siegel GJ, Albers RW, Brady ST, Price DL, eds.). Amsterdam: Elsevier Academic Press, pp. 603-615, 2006.

261. Nixon RA, Yu WH, Cuervo AM, Kumar A, Yang DS, Peterhoff C. Autophagy in Alzheimer's disease: failure of a neuroprotective mechanism. In: Research Advances in Alzheimer Disease and Related Disorders 2004 (Iqbal K, Winblad B, eds.). Alzheimer's Association, Chicago, IL, pp. 190-201, 2005.

262. Klionsky DJ, Emr SD. Autophagy as a regulated pathway of cellular degradation. Science 290: 1717-1721, 2000.

263. Yuan J, Lipinski M, Degterev A. Diversity in the mechanisms of neuronal cell death. Neuron 40: 401-413, 2003.

264. Gonzalez-Polo RA, Boya P, Pauleau AL, Jalil A, Larochette N, Souquere S, Eskelinen EL, Pierron G, Saftig P, Kroemer G. The apoptosis/autophagy paradox: autophagic vacuolization before apoptotic death. J Cell Sci. 118: 3091-3102, 2005.

265. Dikranian K, Ishimaru MJ, Tenkova T, Labruyere J, Qin YQ, Ikonomidou C, Olney JW. Apoptosis in the in vivo mammalian forebrain. Neurobiol Dis. 8: 359-379, 2001.

266. Nicotera P, Leist M, Fava E, Berliocchi L, Volbracht C. Energy requirement for caspase activation and neuronal cell death. Brain Pathol. 10: 276-282, 2000.

267. Reed JC. Mechanisms of apoptosis. Am J Pathol. 157: 1415-1430, 2000.

268. Mattson MP. Mechanisms of neuronal apoptosis and excitotoxicity. In: Pathogenesis of Neurodegenerative Disorders (Mattson MP, ed.). Humana Press, Totowa, NJ, pp. 1-20, 2001.

269. Jellinger KA. Cell death mechanisms in neurodegeneration. J Cell Mol Med. 5: 1-17, 2001.

Roth KA. Caspases, apoptosis, and Alzheimer disease: causation, correlation, and confusion. J Neuropathol Exp Neurol. 60: 829-838, 2001.

Faherty CJ, Smeyne RJ. Cell death in Parkinson's disease. In: Parkinson's Disease (Ebadi M, Pfeiffer RF, eds.). CRC Press, Boca Raton, London, New York, Washington, pp. 523-535, 2005.

Graeber MB, Moran LB. Mechanisms of cell death in neurodegenerative diseases: fashion, fiction, and facts. Brain Pathol. 12: 385-390, 2002.

Hickey MA, Chesselet MF. Apoptosis in Huntington's disease. Prog Neuropsychopharmacol Biol Psychiatry. 2: 255-265, 2003.

Newman J, Rissman RA, Sarsoza F, Kim RC, Dick M, Bennett DA, Cotman CW, Rohn TT, Head E. Caspase-cleaved tau accumulation in neurodegenerative diseases associated with tau and alpha-synuclein pathology. Acta Neuropathol (Berl). 110: 135-144, 2005.

Vis JC, Schipper E, de Boer-van Huizen RT, Verbeek MM, de Waal RM, Wesseling P, Ten Donkelaar HJ, Kremer B. Expression pattern of apoptosis-related markers in Huntington's disease. Acta Neuropathol (Berl). 109: 321-328, 2005.

Sathasivam S, Shaw PJ. Apoptosis in amyotrophic lateral sclerosis - what is the evidence? Lancet Neurol. 4: 500-509, 2005.

Cotman CW, Poon WW, Rissman RA, Blurton-Jones M. The role of caspase cleavage of tau in Alzheimer disease neuropathology. J Neuropathol Exp Neurol. 64: 104-112, 2005.

Fadeel B, Orrenius S. Apoptosis: a basic biological phenomenon with wide-ranging implications inhuman disease. J Intern Med. 258: 479-517, 2005.

Kermer P, Liman J, Weishaupt JH, Baehr M. Neuronal apoptosis in neurodegenerative diseases: from basic research to clinical application. Neurodeg Dis. 1: 9-19, 2004.

Tatton WG, Chalmers-Redman R, Brown D, Tatton N. Apoptosis in Parkinson's disease: signals for neuronal degradation. Ann Neurol. 53(Suppl. 3): S61-S70, discussion S70-S72, 2003. Woodhouse A, Dickson TC, West AK, McLean CA, Vickers JC. No difference in expression of apoptosis-related proteins and apoptotic morphology in control, pathologically aged and Alzheimer's disease cases. Neurobiol Dis. 22: 323-333, 2006.

Culmsee C, Landshamer S. Molecular insights into mechanisms of the cell death program: role in the progression of neurodegenerative disorders. Curr Alzheimer Res. 3: 269-283, 2006. Jellinger KA, Stadelmann C. Problems of cell death in neurodegeneration and Alzheimer's disease. J Alzheimers Dis. 3: 31-40, 2001.

Guo H, Petrin D, Zhang Y, Bergeron C, Goodyer CG, LeBlanc AC. Caspase-1 activation of caspase-6 in human apoptotic neurons. Cell Death Differ. 13: 285-292, 2006.

Kroemer G, Martin SJ. Caspase-independent cell death. Nat Med. 11: 725-730, 2005.

Nicotera P, Melino G. Regulation of the apoptosis-necrosis switch. Oncogene 23: 2757-2765, 2004.

Krantic S, Mechawar N, Reix S, Quirion R. Molecular basis of programmed cell death involved in neurodegeneration. Trends Neurosci. 28: 670-676, 2005.

Gupta VB, Hegde ML, Rao KS. Role of protein conformational dynamics and DNAintegrity in relevance to neuronal cell death in neurodegeneration. Curr Alzheimer Res. 3: 297-309, 2006. Cotman CW, Qian HY, Anderson AJ. Cellular signaling pathways in neuronal apoptosis. Role in neurodegeneration and Alzheimer's disease. In: Cerebral Signal Transduction. From First to Fourth Messengers (Reith MEA, ed.). Humana Press, Totowa, NJ, pp. 175-206, 2000.

Hamdane M, Delobel P, Sambo AV, Smet C, Begard S, Violleau A, Landrieu I, Delacourte A, Lippens G, Flament S, Buee L. Neurofibrillary degeneration of the Alzheimer-type: an alternate pathway to neuronal apoptosis? Biochem Pharmacol. 66: 1619-1625, 2003.

Lassmann H, Bancher C, Breitschopf H, Wegiel J, Bobinski M, Jellinger K, Wisniewski HM. Cell death in Alzheimer's disease evaluated by DNA fragmentation in situ. Acta Neuropathol (Berl). 89: 35-41, 1995.

Sugaya K, Reeves M, McKinney M. Topographic associations between DNA fragmentation and Alzheimer's disease neuropathology in the hippocampus. Neurochem Int. 31: 275-281, 1997. Ayala-Grosso C, Ng G, Roy S, Robertson GS. Caspase-cleaved amyloid precursor protein in Alzheimer's disease. Brain Pathol. 12: 430-441, 2002.

291. Stadelmann C, Deckwerth TL, Srinivasan A, Bancher C, Bruck W, Jellinger K, Lassmann H. Activation of caspase-3 in single neurons and autophagic granules of granulovacuolar degeneration in Alzheimer's disease. Evidence for apoptotic cell death. Am J Pathol. 155: 1459-1466, 1999.

292. Ghoshal N, Smiley JF, DeMaggio AJ, Hoekstra MF, Cochran EJ, Binder LI, Kuret J. A new molecular link between the fibrillar and granulovacuolar lesions of Alzheimer's disease. Am J Pathol. 155: 1163-1172, 1999.

293. Su JH, Kesslak JP, Head E, Cotman CW. Caspase-cleaved amyloid precursor protein and activated caspase-3 are co-localized in the granules of granulovacuolar degeneration in Alzheimer's disease and Down's syndrome brain. Acta Neuropathol (Berl). 104: 1-6, 2002.

294. Wu CK, Thal L, Pizzo D, Hansen L, Masliah E, Geula C. Apoptotic signals within the basal forebrain cholinergic neurons in Alzheimer's disease. Exp Neurol. 195: 484-496, 2005.

295. Engidawork E, Gulesserian T, Yoo BC, Cairns N, Lubec G. Alteration of caspases and apoptosis-related proteins in brains of patients with Alzheimer's disease. Biochem Biophys Res Commun. 281: 84-93, 2001.

296. Raina AK, Hochman A, Zhu X, Rottkamp CA, Nunomura A, Siedlak SL, Boux H, Castellani RJ, Perry G, Smith MA. Abortive apoptosis in Alzheimer's disease. Acta Neuropathol (Berl). 101: 305-310, 2001.

297. Raina AK, Sayre LM, Atwood CS, Rottkamp CA, Hochman Y, Zhu X, Obrenovich ME, Shimohama S, Nunomura A, Takeda A, Perry G, Smith MA. Apoptotic and oxidative indicators in Alzheimer disease. In: Neuromethods, Vol. 37, Apoptosis: Techniques and Protocols, 2nd Edition (LeBlanc AC, ed.). Humana Press, Totowa, NJ, pp. 225-246, 2002.

298. Morsch R, Simon W, Coleman PD. Neurons may live for decades with neurofibrillary tangles. J Neuropathol Exp Neurol. 58: 188-197, 1999.

299. Schwab C, Schulzer M, Steele JC, McGeer PL. On the survival time of a tangled neuron in the hippocampal CA4 region in parkinsonism dementia complex of Guam. Neurobiol Aging 20: 57-63, 1999.

300. Andorfer C, Acker CM, Kress Y, Hof PR, Duff K, Davies P. Cell-cycle reentry and cell death in transgenic mice expressing nonmutant human tau isoforms. J Neurosci. 25: 5446-5454, 2005.

301. SantaCruz K, Lewis J, Spires T, Paulson J, Kotilinek L, Ingelsson M, Guimaraes A, DeTure M, Ramsden M, McGowan E, Forster C, Yue M, Orne J, Janus C, Mariash A, Kuskowski M, Hyman B, Hutton M, Ashe KH. Tau suppression in a neurodegenerative mouse model improves memory function. Science 309: 476-481, 2005.

302. Clarke G, Collins RA, Leavitt BR, Andrews DF, Hayden MR, Lumsden CJ, McInnes RR. A one-hit model of cell death in inherited neuronal degenerations. Nature 406: 195-199, 2000.

303. Levine B, Yuan J. Autophagy in cell death: an innocent convict? J Clin Invest. 115: 2679-2688, 2005.

304. Burke RF. Apoptosis. In: Parkinson's Disease. Diagnosis and Management (Factor SA, Weiner WJ, eds.). Demos Med. Publ. Inc, NY, pp. 291-298, 2002.

304a. Jellinger KA. Challenges in neuronal apoptosis. Curr Alzheimer Res. 3: 377-391, 2006.

305. Motoi Y, Iwamoto H, Itaya M, Kobayashi T, Hasegawa M, Yasuda M, Mizuno Y, Mori H. Four-repeat tau-positive Pick body-like inclusions are distinct from classic Pick bodies. Acta Neuropathol (Berl). 110: 431-433, 2005.

306. Tomidokoro Y, Lashley T, Rostagno A, Neubert TA, Bojsen-Moller M, Braendgaard H, Plant G, Holton J, Frangione B, Revesz T, Ghiso J. Familial Danish dementia: co-existence of Danish and Alzheimer amyloid subunits (ADan AND Ajbetaj) in the absence of compact plaques. J Biol Chem. 280: 36883-36894, 2005.

307. Paisan-Ruiz C, Lang AE, Kawarai T, Sato C, Salehi-Rad S, Fisman GK, Al-Khairallah T, St George-Hyslop P, Singleton A, Rogaeva E. LRRK2 gene in Parkinson disease: mutation analysis and case control association study. Neurology 65: 696-700, 2005.

308. Cairns NJ, Zhukareva V, Uryu K, Zhang B, Bigio E, Mackenzie IR, Gearing M, Duyckaerts C, Yokoo H, Nakazato Y, Jaros E, Perry RH, Lee VM, Trojanowski JQ. Alpha-internexin is present in the pathological inclusions of neuronal intermediate filament inclusion disease. Am J Pathol. 164: 2153-2161, 2004.

309. Paviour DC, Revesz T, Holton JL, Evans A, Olsson JE, Lees AJ. Neuronal intranuclear inclusion disease: report on a case originally diagnosed as dopa-responsive dystonia with Lewy bodies. Mov Disord. 20: 1345-1349, 2004.

310. Mosaheb S, Thorpe JR, Hashemzadeh-Bonehi L, Bigio EH, Gearing M, Cairns NJ. Neuronal intranuclear inclusions are ultrastructurally and immunologically distinct from cytoplasmic inclusions of neuronal intermediate filament inclusion disease. Acta Neuropathol (Berl). 110: 360-368, 2005.

311. Momeni P, Cairns NJ, Perry RH, Bigio E, Gearing M, Singleton AB, Hardy J. Mutation analysis of patients with neuronal intermediate filament inclusion disease (NIFID). Neurobiol Aging 27: 778.e1-778e6, 2006.

312. Sone J, Hishikawa N, Koike H, Hattori N, Hirayama M, Nagamatsu M, Yamamoto M, Tanaka F, Yoshida M, Hashizume Y, Imamura H, Yamada E, Sobue G. Neuronal intranuclear hyaline inclusion disease showing motor-sensory and autonomic neuropathy. Neurology. 65: 1538-1543, 2005.

Unraveling Alzheimers Disease

Unraveling Alzheimers Disease

I leave absolutely nothing out! Everything that I learned about Alzheimer’s I share with you. This is the most comprehensive report on Alzheimer’s you will ever read. No stone is left unturned in this comprehensive report.

Get My Free Ebook


Post a comment